Clinical Trials Directory

Trials / Terminated

TerminatedNCT02492451

Endometrial Injury Versus Luteal Phase Support in Intrauterine Insemination Cycles

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
118 (actual)
Sponsor
Zeynep Kamil Maternity and Pediatric Research and Training Hospital · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The investigators will try to assess the effect of endometrial injury preceding the intrauterine insemination cycle on the pregnancy rates compared to cycles with luteal phase support and the control group.

Detailed description

Group 1: Endometrial biopsy is performed on days 21-24 of the spontaneous menstrual cycle proceeding the intrauterine insemination (IUI) treatment cycle. Two small biopsies are obtained from anterior and posterior walls of the uterus. Group 2: Vaginal progesterone gel is administered for luteal phase support from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy. Goup 3: Patients are undergone intrauterine insemination (IUI) cycles stimulated with gonadotropin without any intervention. The effect of endometrial injury and luteal phase progesterone support on the pregnancy rate in patients intrauterine insemination (IUI) cycles stimulated with gonadotropin will be compared in terms of biochemical pregnancy rate, clinical pregnancy rate and ongoing pregnancy rate.

Conditions

Interventions

TypeNameDescription
OTHEREndometrial InjuryEndometrial injury in luteal phase of preceding cycle by pipelle canula
DRUGprogesterone (Crinone® %8 vaginal progesterone gel)Luteal phase support with progesterone (Crinone® %8 vaginal progesterone gel) in IUI cycle Vaginal progesterone gel is administered from second day after insemination until pregnancy testing and is continued in the presence of pregnancy until the 12 weeks of pregnancy.

Timeline

Start date
2015-06-01
Primary completion
2015-12-01
Completion
2015-12-01
First posted
2015-07-08
Last updated
2016-10-20
Results posted
2016-10-20

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT02492451. Inclusion in this directory is not an endorsement.